1. Home
  2. SRPT vs TFINP Comparison

SRPT vs TFINP Comparison

Compare SRPT & TFINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • TFINP
  • Stock Information
  • Founded
  • SRPT 1980
  • TFINP N/A
  • Country
  • SRPT United States
  • TFINP United States
  • Employees
  • SRPT N/A
  • TFINP 1553
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • TFINP Major Banks
  • Sector
  • SRPT Health Care
  • TFINP Finance
  • Exchange
  • SRPT Nasdaq
  • TFINP Nasdaq
  • Market Cap
  • SRPT N/A
  • TFINP N/A
  • IPO Year
  • SRPT 1997
  • TFINP N/A
  • Fundamental
  • Price
  • SRPT $20.28
  • TFINP $21.73
  • Analyst Decision
  • SRPT Buy
  • TFINP
  • Analyst Count
  • SRPT 26
  • TFINP 0
  • Target Price
  • SRPT $70.92
  • TFINP N/A
  • AVG Volume (30 Days)
  • SRPT 6.5M
  • TFINP N/A
  • Earning Date
  • SRPT 08-06-2025
  • TFINP N/A
  • Dividend Yield
  • SRPT N/A
  • TFINP N/A
  • EPS Growth
  • SRPT N/A
  • TFINP N/A
  • EPS
  • SRPT N/A
  • TFINP N/A
  • Revenue
  • SRPT $2,233,371,000.00
  • TFINP N/A
  • Revenue This Year
  • SRPT $26.87
  • TFINP N/A
  • Revenue Next Year
  • SRPT $3.15
  • TFINP N/A
  • P/E Ratio
  • SRPT N/A
  • TFINP N/A
  • Revenue Growth
  • SRPT 59.15
  • TFINP N/A
  • 52 Week Low
  • SRPT $18.30
  • TFINP N/A
  • 52 Week High
  • SRPT $173.25
  • TFINP N/A
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 20.82
  • TFINP 50.17
  • Support Level
  • SRPT $18.30
  • TFINP $21.21
  • Resistance Level
  • SRPT $22.98
  • TFINP $22.50
  • Average True Range (ATR)
  • SRPT 2.20
  • TFINP 0.49
  • MACD
  • SRPT -1.46
  • TFINP -0.06
  • Stochastic Oscillator
  • SRPT 8.90
  • TFINP 34.56

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About TFINP Triumph Financial Inc.

Triumph Financial Inc is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Intelligence. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The Intelligence segment includes to turn the over-the-road trucking data collected through the services into actionable insights for their customers.

Share on Social Networks: